Integrating sodium cholate-modified MOF hybrid lipase and solubilization of hydrophobic candidates into a step for liganding fishing lipase inhibitors from Nelumbinis Folium.

Lipase inhibitors Molecular docking Nelumbinis Folium Sodium cholate Zeolitic imidazolate framework-8

Journal

Journal of pharmaceutical and biomedical analysis
ISSN: 1873-264X
Titre abrégé: J Pharm Biomed Anal
Pays: England
ID NLM: 8309336

Informations de publication

Date de publication:
27 Aug 2024
Historique:
received: 10 06 2024
revised: 08 08 2024
accepted: 18 08 2024
medline: 31 8 2024
pubmed: 31 8 2024
entrez: 28 8 2024
Statut: aheadofprint

Résumé

Enzyme immobilization by metal organic frameworks (MOFs) is an efficient way for screening active constituents in natural products. However, the enzyme's biocatalysis activity is usually decreased due to unfavorable conformational changes during the immobilization process. In this study, sodium cholate was firstly used as the modifier for zeolitic imidazolate framework-8 (ZIF-8) immobilized lipase to increase both the stability and activity. More importantly, with the help of solubilization of sodium cholate, a total of 3 flavonoids and 6 alkaloids candidate compounds were fished out. Their structures were identified and the enzyme inhibitory activities were verified. In addition, the binding information between the candidate compound and the enzyme was displayed by molecular docking. This study provides valuable information for the improvement of immobilized enzyme activity and functional active ingredients in complicated medicinal plant extracts.

Identifiants

pubmed: 39197203
pii: S0731-7085(24)00470-9
doi: 10.1016/j.jpba.2024.116430
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

116430

Informations de copyright

Copyright © 2024 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no conflicts of interest.

Auteurs

Wenxiang Hu (W)

College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, PR China.

Jiayun Li (J)

College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, PR China.

Xindan Zhang (X)

College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, PR China.

Yangbin Lv (Y)

College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, PR China.

Hongwei Ye (H)

College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, PR China.

Chenyue Li (C)

College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, PR China.

Ehu Liu (E)

College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, PR China. Electronic address: liuehu2011@163.com.

Chu Chu (C)

College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, PR China. Electronic address: chuchu@zjut.edu.cn.

Classifications MeSH